City Dealmakers Bet on a Rebound in UK M&A

After two years of muted activity, the UK M&A market is showing unmistakable signs of life. Senior investment bankers, private equity executives, and corporate finance chiefs are reporting a marked acceleration in deal flow, with transaction volumes climbing and valuations stabilising after a prolonged period of investor caution.

The momentum has become visible across multiple indicators. Advisers are busy with outbound mandates from blue-chip corporates seeking acquisitions; family offices and PE firms are actively bidding for mid-market assets; and a sustained recovery in equity markets has restored confidence in both buyer and seller psychology. For CEOs navigating a complex macroeconomic backdrop—volatile interest rates, regulatory scrutiny, and sector-specific headwinds—the reopening of the dealmaking calendar represents a critical strategic window.

This resurgence matters because M&A activity often precedes broader economic confidence. Where corporations are willing to deploy capital, commit to large balance sheet moves, and take on integration risk, it signals genuine belief in future growth prospects. Understanding which sectors, deal types, and business models are driving this rebound reveals where UK leadership sees opportunity—and where competitive necessity is forcing action.

The Numbers: M&A Activity Climbing Off the Floor

The Bank of England's latest financial stability report and transaction data from financial advisers point to a measurable shift. The Financial Conduct Authority and major investment banking advisory teams have documented a sustained uptick in deal origination throughout Q1 and Q2 2026.

According to feedback from leading UK-headquartered investment banks and independent advisory firms, transaction volumes in the first half of 2026 are tracking at levels not seen since 2021. The value of announced UK M&A deals has climbed back towards £50–60 billion run-rate, after falling to historic lows during 2024–2025. Importantly, this is not driven by a handful of mega-deals; instead, activity is broad-based, with a healthy pipeline of mid-market transactions valued between £50 million and £500 million—the segment most closely watched by operating companies and institutional investors.

Private equity dry powder remains substantial. According to recent industry reporting from Preqin and data compiled by the British Private Equity and Venture Capital Association, UK-focused PE funds hold approximately £70–80 billion of uninvested capital. Combined with the appetite of larger buyout firms and continuation funds, this represents a significant pool of capital competing for assets. The result: seller sentiment has shifted sharply. Family business owners, corporate boards, and institutional shareholders are increasingly willing to test market appetite for asset sales.

"The phone has been ringing again," one London-based corporate finance partner at a top-ten advisory firm noted in recent conversations with CEO Weekly. "Six months ago, we had outbound mandates sitting idle. Now we're triaging multiple concurrent processes. Buyers are back."

Defensive Positioning and Portfolio Consolidation

A significant portion of current M&A activity reflects defensive corporate strategy. After years of cost-cutting and margin preservation, UK corporates are now actively reshaping their portfolio mix—divesting non-core or underperforming units while acquiring assets that strengthen core competitive position or plug capability gaps.

In the manufacturing and engineering sectors, consolidation is pronounced. Mid-sized industrial companies are acquiring smaller specialists to build scale, invest in ESG-compliant operations, and secure supply chain resilience. Several FTSE 250 companies have publicly flagged acquisition pipelines in recent investor updates, citing the need to achieve critical mass in specific geographies or technical domains.

The financial services sector is also active. Following tighter capital adequacy requirements from the PRA (Prudential Regulation Authority) and ongoing competitive pressure from neobanks and fintech players, traditional banks and wealth managers are acquiring specialist advisory teams, asset management boutiques, and digital platforms. This trend reflects a deliberate strategy: consolidate to compete against larger global players while capturing niche market segments where scale is less critical than expertise.

Retail and consumer goods companies are pursuing a mix of tuck-in acquisitions and larger platform buys. The shift toward omnichannel retail, e-commerce integration, and direct-to-consumer models is driving acquisitions of digital-native brands and logistics capability. Several large consumer groups have announced or completed acquisitions of smaller DTC brands, particularly in sustainable and premium segments where younger consumer demographics are concentrated.

"Boards are no longer playing defence by cost-cutting alone," explains a senior M&A lawyer at a leading UK firm. "They're now asking: what do we need to acquire to remain competitive? That shift in mindset is fuel for deal flow."

Sectors Leading the Rebound: Tech, Health, and Green Infrastructure

Not all sectors are equal in the current market. Three domains stand out as drivers of disproportionate deal activity:

Digital Infrastructure and Connectivity

Investment in UK broadband, data centres, and digital connectivity infrastructure remains a strategic priority for both corporates and institutional capital. Rural broadband projects continue to attract funding from government schemes and private investors. Specialist companies providing backbone connectivity solutions to underserved regions, such as rural broadband provider Voove, operate in a market where demand for acquisition or partnership is steady. Larger telecoms operators and infrastructure funds are actively acquiring smaller regional broadband players as they consolidate market share and expand geographic coverage ahead of anticipated further regulatory change.

Healthcare and Life Sciences

The NHS spending trajectory and private healthcare expansion have created clear targets for acquisition. Diagnostic laboratories, specialist treatment centres, and health-tech platforms are attracting both PE interest and strategic buyers. The Competition and Markets Authority has scrutinised several larger healthcare consolidations, but mid-market acquisitions continue to flow. Private equity backing of diagnostic and outpatient services providers is particularly active, with GPs citing sector tailwinds driven by ageing demographics and sustained private health insurance uptake among affluent UK consumers.

Green Energy and Sustainability Infrastructure

The government's continued commitment to net-zero targets and renewable energy expansion is driving M&A. Renewable energy projects, battery storage operators, and sustainability consulting firms are attracting strategic buyers and infrastructure-focused PE. Several large utilities and infrastructure funds have announced acquisition pipelines in wind, solar, and energy storage. The Energy Bill Relief Scheme's expiration and evolving support mechanisms have also prompted consolidation among smaller renewable operators seeking balance sheet strength.

CEO Strategy: Growth vs Defensive Acquisitions

How today's leaders view M&A reveals their strategic posture. Broadly, current dealmaking splits into two camps:

Growth Acquisitions: Companies with strong market position and cash generation are pursuing bolt-on acquisitions to accelerate top-line growth, enter adjacent markets, or acquire technical talent and IP. This is most visible in software, professional services, and specialist manufacturing. For these buyers, M&A is offensive—a way to speed market expansion when organic growth alone feels insufficient.

Some FTSE 250 companies have flagged growth-via-acquisition as an explicit strategic pillar in recent investor presentations. The logic is straightforward: organic growth in mature UK markets faces headwinds; acquiring smaller, faster-growing rivals or adjacent players can unlock revenue synergies and margin upside more quickly than organic investment.

Defensive/Portfolio Consolidation: Other leaders are focused on shedding non-core assets, reallocating capital to higher-return segments, and rationalising cost bases. This is typical among diversified groups, legacy industrial companies, and businesses facing structural headwinds in specific segments. Asset sales also generate cash to reduce leverage, fund shareholder returns, or invest in transformation.

Both approaches are rational in today's environment. The key indicator of management confidence is which strategy dominates. Current evidence suggests a mix: growth-hungry companies are acquiring, while others are trimming portfolios—consistent with a market where confidence is returning but selectivity remains high.

Valuation Reality and Deal Structure

A critical constraint on deal volume is valuation. Unlike the pre-2020 period, when multiple expansion was rapid and cost of capital was negligible, current M&A negotiations are more disciplined.

Sellers' expectations have adjusted, but not uniformly. Well-positioned, cash-generative businesses are realising valuations near or at pre-pandemic levels. Cyclical or leveraged businesses, or those dependent on falling interest rates, face more cautious buyer interest.

Debt financing remains available but expensive. Bank loan spreads have normalised, and PE sponsors are more rigorous about leverage multiples. The days of 6–7x EBITDA financing are gone; most deals are structured at 4–5x leverage, with equity cheques larger relative to debt. This disciplines pricing but also raises the bar for acquisition economics to clear required returns.

Earn-out structures and deferred consideration are more prevalent than in the 2015–2019 period, reflecting buyer caution about integration risk and post-deal performance. Sellers accept deferred consideration because the alternative—accepting a lower upfront price—is less attractive.

The regulatory environment also shapes deal structure. The Competition and Markets Authority has been active in reviewing large transactions, particularly in concentrated sectors. This is prompting sponsors and corporates to build in regulatory approval contingencies and divestment readiness earlier in the process. Several large UK deals announced in 2025–2026 have explicitly flagged CMA review as a factor in timeline planning.

Private Equity Appetite and Continuation Funds

Private equity remains a significant force in UK M&A. The combination of dry powder, strong performance from recent vintage funds, and GP-led secondary activity is maintaining robust PE bidding.

Continuation funds—vehicles that extend investment horizons for existing portfolio companies—are particularly active. Rather than sell mature investments to trade buyers, GPs are using continuation vehicles to hold assets longer, compound returns, and potentially pair them with other portfolio companies. This is less visible in headline deal count but materially absorbs capital that might otherwise deploy via traditional acquisitions.

Middle-market PE (targeting £50–250 million EBITDA) is especially active. The sweet spot for UK PE—founders and families looking to sell, management teams willing to stay, and businesses with clear value-creation roadmaps—remains abundant. Deal multiples for well-run mid-market businesses are stabilising around 7–9x EBITDA, up from trough levels but below the 10–12x seen in 2021.

Regulatory and Macro Headwinds

Dealmaking is not frictionless. Several factors constrain velocity and complexity:

Interest Rates and Cost of Capital: While rates have stabilised, they remain elevated relative to the 2010–2021 period. Leveraged acquisitions face higher financing costs, compressing IRRs and requiring more disciplined underwriting. Rising rates also reduce the discount rate applied to future cash flows, pressuring valuations for growth-dependent targets.

CMA Scrutiny: The Competition and Markets Authority has been active post-2024, reviewing several large transactions and challenging some proposed mergers in concentrated sectors. While most mid-market deals are not flagged, larger transactions increasingly factor in CMA review timelines and potential remedies (divestitures, behavioural commitments) into deal structure.

Tax and Regulatory Change: The government's ongoing consultation on corporation tax, potential changes to M&A-related tax relief, and evolving ESG disclosure requirements add complexity and cost to dealmaking. Sellers and buyers must factor in tax efficiency across multiple regimes, and larger deals often require external tax counsel and regulatory expert input.

Talent and Integration Risk: In a tight labour market, integration risk is material. Key person retention, cultural alignment, and talent acquisition post-close are elevated concerns. Deals that create significant redundancy or involve integration of competing support functions face higher execution risk.

Forward Look: Where Dealmaking Is Headed

The consensus among dealmakers is that M&A velocity will remain elevated through H2 2026 and into 2027, barring a sharp economic downturn. Three dynamics support this outlook:

Pent-up Supply: Sellers have been patient. Many family and founder-led businesses, and some corporate boards, have been holding assets off market waiting for valuations to recover. That moment appears to have arrived for many. A significant pipeline of sell-side mandates is expected to come to market in the coming 6–12 months.

PE Deployment Pressure: Large GP commitments from LPs mean fund managers have capital to deploy. Near-term deployment cycles will keep PE competitive and disciplined, supporting deal flow even if equity markets dip.

Strategic Inevitability: Sector consolidation in manufacturing, healthcare, professional services, and digital infrastructure is structural, not cyclical. CEOs recognising the need for scale, capability, or market position will continue to pursue M&A as a core strategy. Cost inflation and labour market tightness reinforce the case for consolidation to achieve operational leverage.

However, three wild cards could disrupt this trajectory: a sharp rise in interest rates, a recession triggered by external shock, or material policy change (e.g., significant CMA intervention or punitive tax treatment of M&A). Dealmakers are monitoring these carefully, but current base case assumes a steady rebound with selective, disciplined deal activity driving volumes.

For CEOs, the message is clear: the dealmaking window is open. Asset valuations are stabilising, capital is available, and strategic rationale for M&A is sound across multiple sectors. The question is not whether to pursue M&A, but whether your business can articulate a compelling case for growth via acquisition, and execute integration effectively. Those who move decisively in this window will shape competitive position for the next decade.

Related Reading: